ID

34184

Descrição

Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention; ODM derived from: https://clinicaltrials.gov/show/NCT01442792

Link

https://clinicaltrials.gov/show/NCT01442792

Palavras-chave

  1. 15/01/2019 15/01/2019 -
Titular dos direitos

see on clinicaltrials.gov

Transferido a

15 de janeiro de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Cardiovascular Disease, Coronary Artery Disease NCT01442792

Eligibility Cardiovascular Disease, Coronary Artery Disease NCT01442792

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female subject aged 18 years or more with no upper age limit and willing to comply with the protocol
Descrição

ID.1

Tipo de dados

boolean

symptomatic coronary artery disease due to undergo an elective (non-emergent) percutaneous coronary intervention (pci) on one or two lesions in the native coronary vessel(s). cardiac standard troponin at baseline is within the normal limits
Descrição

ID.2

Tipo de dados

boolean

Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
conditions that may increase the risk of the pci procedure
Descrição

ID.3

Tipo de dados

boolean

conditions that may increase the risk of bleeding
Descrição

ID.4

Tipo de dados

boolean

significant valvular heart disease
Descrição

ID.5

Tipo de dados

boolean

calculated creatinine clearance ≤30 ml/min
Descrição

ID.6

Tipo de dados

boolean

current use of anticoagulant drugs including vitamin k antagonist (vka), factor iia or factor xa inhibitors
Descrição

ID.7

Tipo de dados

boolean

chronic treatment with non-steroidal anti-inflammatory drugs (nsaids)
Descrição

ID.8

Tipo de dados

boolean

chronic treatment with aspirin > 100mg
Descrição

ID.9

Tipo de dados

boolean

Similar models

Eligibility Cardiovascular Disease, Coronary Artery Disease NCT01442792

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
male or female subject aged 18 years or more with no upper age limit and willing to comply with the protocol
boolean
ID.2
Item
symptomatic coronary artery disease due to undergo an elective (non-emergent) percutaneous coronary intervention (pci) on one or two lesions in the native coronary vessel(s). cardiac standard troponin at baseline is within the normal limits
boolean
Item Group
C0680251 (UMLS CUI)
ID.3
Item
conditions that may increase the risk of the pci procedure
boolean
ID.4
Item
conditions that may increase the risk of bleeding
boolean
ID.5
Item
significant valvular heart disease
boolean
ID.6
Item
calculated creatinine clearance ≤30 ml/min
boolean
ID.7
Item
current use of anticoagulant drugs including vitamin k antagonist (vka), factor iia or factor xa inhibitors
boolean
ID.8
Item
chronic treatment with non-steroidal anti-inflammatory drugs (nsaids)
boolean
ID.9
Item
chronic treatment with aspirin > 100mg
boolean

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial